SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PROTEOMICS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject10/10/2000 4:23:45 PM
From: nigel bates   of 539
 
Oct. 10 /PRNewswire/ -- Proteome Systems announced today the opening of a US proteomics factory in Woburn, Massachusetts on 16 October 2000. The 21,000 square feet, state-of-the-art factory will allow the company to carry out high throughput proteomics discovery programs and accelerate the development of its proprietary high throughput proteomics technology platform. The factory will include a demonstration and training facility to showcase the company's leading edge proteomics capabilities. The facility is configured for GMP/GLP certification which will ensure adherence to the highest standards of manufacture and discovery program execution.
Proteome Systems intends to release the front end components of its technology platform to the market in first quarter 2001. The balance of the platform will be available progressively over the following 12 months. The technology platform is currently being beta tested in the company's in-house discovery programs in Sydney.
The Boston team will be led by Dr Bill Skea, Dr Mary Lopez and Dr Malcolm Pluskal, three of the leading proteomics scientists in the industry.
CEO, Keith Williams said ``The opening of our Boston proteomics factory brings together the complementary skills of two of the most experienced proteomics teams in the market. The combination of intellectual leadership in protein science and commercialistion of proteomics technologies strategically positions the company to lead the race in defining the human proteome.''
Proteome Systems is a leading proteomics-based technology development and discovery company headquartered in Sydney with a substantial intellectual property estate underlying its technology platform and discovery programs.
web: www.proteomesystems.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext